Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients

scientific article published on 01 July 1993

Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0091-6749(93)90043-F
P953full work available at URLhttps://doi.org/10.1016/0091-6749(93)90043-f
https://api.elsevier.com/content/article/PII:009167499390043F?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:009167499390043F?httpAccept=text/plain
P698PubMed publication ID7687608

P2093author name stringM. A. Kaliner
M. V. White
R. J. Hohman
H. C. Kaulbach
B. L. Mosimann
M. S. Goldrich
P433issue1 Pt 1
P407language of work or nameEnglishQ1860
P304page(s)95-104
P577publication date1993-07-01
P1433published inThe Journal of Allergy and Clinical ImmunologyQ7743550
P1476titleSubstance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients
P478volume92

Reverse relations

cites work (P2860)
Q37015446A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.
Q39671915Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis
Q104064365Allergic rhinitis
Q36795267Bitter and sweet taste receptors in the respiratory epithelium in health and disease
Q71289849Calcitonin gene-related peptide in vitro stimulation of ciliary beat in human upper respiratory cilia
Q49064177Capsaicin-induced vasodilatation in human nasal vasculature is mediated by modulation of cyclooxygenase-2 activity and abrogated by sulprostone.
Q38196334Cytokine profiles in allergic rhinitis
Q73147021Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps
Q71439397Determination of substance P in human nasal lavage fluid
Q47878498Distribution and quantity of neuroendocrine markers in allergic rhinitis
Q35110517Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons
Q48758082Effect of intravenous calcitonin gene-related peptide antagonist on the laryngeal chemoreflex in piglets.
Q32019400Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis
Q58083612Expression of Substance P (NK1) Receptor mRNA in Human Nose
Q80725498Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method
Q35552822H1-receptors: localization and role in airway physiology and in immune functions
Q72192519HLA immunogenetics and specific IgE responses to allergens
Q33855065Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease
Q30498710Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans
Q52594640Interactions of the immune and sensory nervous systems in atopy.
Q81886305Intranasal trigeminal sensitivity in subjects with allergic rhinitis
Q38907362Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography
Q71843769Lack of association between HLA‐DQ and ‐DR genotypes and asthma in southern Chinese patients
Q36836039Measurement of bioactive neuropeptides using a chromatographic immunosensor cartridge
Q77759930Mechanisms of allergic rhinitis
Q44163611Nasal and skin histamine responses in allergic rhinitis
Q54079157Nasal reactivity to capsaicin in patients with seasonal allergic rhinitis during and after the pollen season.
Q36793272Nasonasal reflexes, the nasal cycle, and sneeze
Q44355180Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis
Q47800446Neuro-immune interactions in allergic diseases: novel targets for therapeutics
Q47921833Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases
Q42572503Neurogenic inflammation in human airways: is it important?
Q34561650Neurogenic mechanisms in rhinosinusitis
Q82423208Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP)
Q89581125Neuropeptide regulation of secretion and inflammation in human airway gland serous cells
Q42138353Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models
Q33750651Pathophysiology of the inflammatory response
Q42708177Potentiation by viral respiratory infection of ovalbumin‐induced guinea‐pig tracheal hyperresponsiveness: role for tachykinins
Q58596146Role of Taste Receptors as Sentinels of Innate Immunity in the Upper Airway
Q33899646Role of tachykinins in asthma
Q37215899Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid
Q40461697Taste Receptors: Regulators of Sinonasal Innate Immunity.
Q38260860Taste receptors in innate immunity
Q34493847Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis.
Q34366396The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy.
Q36795289The Role of Bitter and Sweet Taste Receptors in Upper Airway Immunity.
Q64911505The role of bitter and sweet taste receptors in upper airway innate immunity: Recent advances and future directions.
Q41757345The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
Q37346160Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration
Q37360187Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells
Q34561632Viral rhinitis
Q80196993[Auricular chondritis. Experimental model in rats]

Search more.